April 18, 2017
Faron to test its immuno switch antibody with the University of Birmingham Medical School
Faron Pharmaceuticals and the University of Birmingham Medical School, have signed an agreement to begin a liver cancer program for clinical testing of Faron’s immuno switch antibody Clevegen.